Pax will also release a co-branded vaporizer as part of Aphria’s medical cannabis launch kit.
NORTH AMERICA–Canadian lifestyle brand Tokyo Smoke has joined forces with Aphria, one of Canada’s largest licensed producers of medical marijuana, to introduce four strains of medical cannabis.
Grown and distributed by Aphria, under the Access to Cannabis for Medical Purposes Regulations, the new strains–Tokyo Smoke G (sativa), Tokyo Smoke Rx (indica), Tokyo Smoke Rf (sativa) and Tokyo Smoke B (hybrid)–will be available to Canadian patients with valid medical prescriptions as part of a kit featuring Tokyo Smoke packaging, five grams of each strain as well as custom black glass jars and accessories. The kits will be available through the Aphria website beginning Aug. 24.
Tokyo Smoke has also partnered with Pax, a vaporizer company, to create a co-branded Pax 3, marking the first time Pax has partnered with a cannabis brand. The co-branded vaporizers will only be available through the Tokyo Smoke x Aphria launch kit.